Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm, Phase 1/2 Study of SNX-5422 in Subjects With Selected HER2 Positive Cancers.

NCT01848756 is registered in ClinicalTrials.gov with Esanex Inc. as lead sponsor.

NCT NCT01848756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01848756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm, Phase 1/2 Study of SNX-5422 in Subjects With Selected HER2 Positive Cancers.
Lead sponsor
Esanex Inc.
Phase
Phase 1/2
Overall status
Terminated
Start date
April 30, 2013
Completion date
June 30, 2015
Enrollment
15 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cancer